More on INO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+75.9% Growth)
- Ratings (6.1 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inovio Pharma (NQ:INO)
Delayed: 1.43 +0.07 (5.15%)
Prev. Close $1.36  
Open$1.35 
52 Wk High$11.69 
52 Wk Low$4.50 
Day High$1.43 
Day Low$1.35 
P/E N/A  
EPS$-0.28 
Volume2,910,141 

Friends, Peers and Foes (?): ORCL, PSFE, TCPC, KD, HKEX (more...)

Sep 1, 2026 04:05 PM INOVIO to Participate in Upcoming Investor Conferences
Aug 13, 2026 07:04 AM H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
Aug 13, 2026 04:37 AM Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy
Aug 12, 2026 04:38 PM Inovio Pharma (INO) Tops Q2 EPS by 18c
Aug 12, 2026 04:08 PM Form 8-K INOVIO PHARMACEUTICALS, For: Aug 12
Aug 12, 2026 04:05 PM INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 12, 2026 04:01 PM Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
Aug 12, 2026 12:03 PM Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
Aug 7, 2026 04:14 PM Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 6, 2026 10:32 AM Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: FMR LLC
View All Articles

Entities mentioned with INO

View All Entities